Cytokines are basically the immune system’s group chat: short messages that tell cells when to inflame, recruit help, calm down, or start building long-term memory. On Step 1, the trick isn’t memorizing 50 random facts—it’s recognizing patterns (which T helper subset made it, what it does, and what disease/drug screams that cytokine). This guide is a high-yield, IL-1 through IL-17 deep dive with mechanisms, classic clinical correlations, and “what to do with it” thinking.
The big picture: what cytokines are and why Step 1 loves them
Cytokines = small signaling proteins (usually glycoproteins) that act via autocrine, paracrine, and sometimes endocrine effects. They coordinate:
- Innate immunity: fever, acute-phase response, neutrophil recruitment, macrophage activation
- Adaptive immunity: T-cell differentiation (Th1/Th2/Th17/Tfh/Treg), B-cell help, class switching, cytotoxic responses
- Hematopoiesis: growth/differentiation of immune cell lines (overlaps with colony-stimulating factors)
Step strategy: When you see an IL in a vignette, ask:
- Source: macrophage? Th1? Th2? Th17? Treg? dendritic cell?
- Target effect: neutrophils vs eosinophils vs macrophages vs B cells
- Clinical hook: fever/shock, granulomas, allergy/asthma, autoimmunity, hyper-IgE, chronic mucocutaneous candidiasis, etc.
- Drug hook: anakinra/canakinumab (IL-1), tocilizumab (IL-6), ustekinumab (IL-12/23), secukinumab (IL-17), dupilumab (IL-4/13)
First Aid cross-reference (general): Immunology chapter → cytokines, T-cell subsets (Th1/Th2/Th17/Treg), inflammation/fever; Rheumatology/Derm (psoriasis), GI (IBD), MSK (RA), Hem/Onc (HLH/macrophage activation).
Quick high-yield map (memorize this first)
T helper subset → cytokines → purpose
| Subset | Signature cytokines | Main job | HY associations |
|---|---|---|---|
| Th1 | IFN-γ, IL-2 (not in this post), promotes IL-12 feedback | Intracellular pathogens, macrophage activation | Granulomas, delayed-type hypersensitivity |
| Th2 | IL-4, IL-5, IL-13 | Parasites, allergy, IgE, eosinophils, mucus | Asthma, atopy, helminths |
| Th17 | IL-17, IL-22 (not in this post) | Neutrophil recruitment, barrier defense | Candida, S. aureus; psoriasis/SpA |
| Treg | IL-10, TGF-β (not in this post) | Immune suppression/tolerance | Autoimmunity prevention |
IL-by-IL Deep Dive (IL-1 → IL-17)
IL-1 (IL-1β): “Fever + inflammation starter”
Definition / source
- Potent pro-inflammatory cytokine
- Produced mainly by macrophages/monocytes, dendritic cells (often downstream of inflammasome activation)
Pathophysiology (what it does)
- Induces fever (acts on hypothalamus → ↑ PGE₂)
- Upregulates endothelial adhesion molecules → leukocyte extravasation
- Promotes acute inflammation, synergizes with TNF-α and IL-6
Clinical presentation (think IL-1 when you see…)
- Fever, malaise, systemic inflammatory picture
- Autoinflammatory syndromes (inflammasomopathies) with recurrent fevers:
- Familial Mediterranean fever (colchicine classically)
- Cryopyrin-associated periodic syndromes (CAPS)
Diagnosis (Step-style)
- Mostly clinical; labs show elevated inflammatory markers (CRP/ESR)
- In autoinflammatory disease: episodic fevers, sterile inflammation; genetic testing sometimes
Treatment / drug hooks
- Anakinra = IL-1 receptor antagonist
- Canakinumab = anti–IL-1β monoclonal antibody
Used in CAPS, Still disease, gout flares (select cases), and other IL-1–driven states.
First Aid tie-in
- Cytokines of fever/inflammation; “IL-1 → fever” is a classic FA bullet.
IL-2: (Classic but not in your requested range focus—still worth 1 line)
Even though your prompt is IL-1–IL-17, remember: IL-2 = T-cell proliferation (made by Th1). Shows up constantly.
IL-3: “Bone marrow support”
Definition / source
- Produced by activated T cells (also mast cells)
Pathophysiology
- Supports growth and differentiation of bone marrow progenitors
- Overlaps conceptually with CSFs (GM-CSF)
Clinical hooks
- Less commonly tested directly; think hematopoiesis support / marrow stimulation context.
First Aid tie-in
- Often listed among cytokines promoting bone marrow growth.
IL-4: “Th2 + IgE + class switch”
Definition / source
- Produced by Th2 cells, mast cells, basophils
Pathophysiology
- Drives Th2 differentiation
- Promotes B-cell class switching to IgE (and IgG4)
- Supports alternative macrophage activation; allergy phenotype
Clinical presentation
- Atopic disease: allergic rhinitis, asthma, eczema (Th2 skew)
- Helminth immune response (paired with IL-5 eosinophils)
Diagnosis
- Not measured routinely; inferred from clinical phenotype (atopy, eosinophilia, high IgE)
Treatment / drug hooks
- Dupilumab = blocks IL-4 receptor α (thereby inhibits IL-4 and IL-13 signaling)
Used for atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps.
First Aid tie-in
- Th2 cytokines: IL-4, IL-5, IL-13.
IL-5: “Eosinophils”
Definition / source
- Produced by Th2 cells and mast cells
Pathophysiology
- Eosinophil growth and activation
- Promotes IgA production (sometimes noted), but eosinophils are the Step 1 anchor
Clinical presentation
- Eosinophilia in:
- Asthma
- Allergic disease
- Parasitic infections (helminths)
Diagnosis
- CBC shows eosinophilia; clinical context points to Th2/IL-5 axis
Treatment / drug hooks
- Anti–IL-5 therapies (high yield more for Step 2, but useful):
- Mepolizumab/reslizumab (anti–IL-5), benralizumab (anti–IL-5R) for eosinophilic asthma
First Aid tie-in
- IL-5 is the “eosinophil cytokine” in Th2 list.
IL-6: “Acute phase + fever + hepcidin”
Definition / source
- Produced by macrophages, T cells, endothelial cells, fibroblasts
Pathophysiology
- Triggers acute-phase response in liver → ↑ CRP, fibrinogen
- Induces fever
- Stimulates hepcidin → anemia of chronic disease (decreased iron availability)
- Helps B-cell differentiation (plasma cells)
Clinical presentation
- Systemic inflammatory states with:
- Elevated CRP
- Anemia of chronic disease
- Important in rheumatoid arthritis, giant cell arteritis, cytokine-release syndromes
Diagnosis
- Labs: ↑ CRP, anemia of chronic inflammation pattern (low iron, low TIBC, normal/high ferritin)
Treatment / drug hooks
- Tocilizumab (anti–IL-6 receptor) for RA, GCA, and cytokine release syndrome management
First Aid tie-in
- IL-6 → acute phase reactants; connect to CRP and hepcidin.
IL-7: “Lymphocyte development”
Definition / source
- Produced by bone marrow stromal cells and thymic stromal cells
Pathophysiology
- Required for B-cell development (in bone marrow)
- Required for T-cell development (in thymus)
Clinical presentation (boards logic)
- Defects in IL-7 signaling can contribute to severe lymphopenia/SCID-like phenotypes (conceptual linkage)
Diagnosis
- Immunodeficiency workup: low T (and sometimes B) cell counts depending on pathway involved
First Aid tie-in
- IL-7 is classically “T and B cell development.”
IL-8 (CXCL8): “Neutrophil chemotaxis”
Definition / source
- Chemokine produced by macrophages and other cells (endothelial cells)
Pathophysiology
- Strong neutrophil chemotactic factor
- Recruits neutrophils to sites of infection/inflammation
Clinical presentation
- Acute bacterial infection pattern with neutrophil-predominant inflammation
- Frequently used as the conceptual basis for “why neutrophils show up first”
Diagnosis
- Not typically ordered; inferred from neutrophil-rich inflammation (e.g., abscess)
First Aid tie-in
- IL-8 → neutrophil chemotaxis (classic one-liner).
IL-9: “Mast cells + mucus (often paired with Th2)”
Definition / source
- Produced by Th2 (and sometimes described with Th9 subset, depending on resource depth)
Pathophysiology
- Promotes mast cell growth
- Supports mucus production and allergic inflammation
Clinical hooks
- Allergy/asthma “supporting actor”—less frequently tested than IL-4/5/13
First Aid tie-in
- Sometimes listed among Th2-associated cytokines; not always emphasized.
IL-10: “Brake pedal”
Definition / source
- Produced by Treg cells (also macrophages, some Th2 contexts)
Pathophysiology
- Anti-inflammatory: decreases Th1 cytokines, reduces antigen presentation (↓ MHC II), dampens macrophage activation
- Promotes immune tolerance and limits tissue damage
Clinical presentation
- Loss of IL-10 function → tendency toward excess inflammation and autoimmunity/IBD-like disease (conceptual)
- High IL-10 states can contribute to immunosuppression (e.g., chronic infection persistence conceptually)
Diagnosis
- Typically conceptual rather than measured; think “why inflammation is unchecked”
Treatment
- Not a common direct therapeutic target on boards; more often used to understand regulation
First Aid tie-in
- Treg cytokines: IL-10 (and TGF-β) → inhibits immune response.
IL-11: “Megakaryocytes/platelets (rarely tested)”
Definition / source
- Produced by stromal cells and others
Pathophysiology
- Supports megakaryocyte maturation and platelet production (overlaps with thrombopoietic signals)
Clinical hooks
- Low yield for Step 1 compared with IL-1/6/8/12/17; know it’s hematopoiesis-adjacent.
IL-12: “Th1 + NK activation”
Definition / source
- Produced by macrophages and dendritic cells
Pathophysiology
- Drives Th1 differentiation
- Activates NK cells
- Enhances cell-mediated immunity → intracellular pathogen killing via macrophage activation (through IFN-γ downstream)
Clinical presentation
- Defects → susceptibility to intracellular pathogens
- Think disseminated mycobacterial/fungal infections in impaired Th1 axis
Diagnosis
- Immunodeficiency evaluation; clinical pattern of severe intracellular infections
Treatment / drug hooks
- Ustekinumab blocks IL-12/23 (p40 subunit) → used in psoriasis and IBD (Crohn’s)
First Aid tie-in
- IL-12 is the classic Th1 inducer and NK activator.
IL-13: “Mucus + airway hyperreactivity”
Definition / source
- Produced by Th2 cells
Pathophysiology
- Promotes IgE production (overlaps with IL-4)
- Increases mucus production
- Contributes to airway hyperresponsiveness and remodeling in asthma
Clinical presentation
- Asthma phenotypes (mucus plugging, hyperreactivity)
- Atopic disease
Diagnosis
- Clinical; not typically measured
Treatment / drug hooks
- Dupilumab (IL-4Rα blockade) hits IL-13 signaling too
First Aid tie-in
- Th2 cytokine list; IL-13 = “mucus” is a great memory hook.
IL-14 & IL-15: quick notes (variable emphasis across resources)
These are less consistent in Step 1 “must-know” lists, but they occasionally show up in deeper immunology.
IL-15: “NK cells (and memory CD8 support)”
- Produced by mononuclear phagocytes and others
- Supports NK cell development and survival; helps memory CD8+ T cells
- Useful association: overlaps conceptually with IL-2 in lymphocyte proliferation/survival
IL-16: “CD4 chemoattractant (low yield)”
- Functions as a chemoattractant for CD4+ cells
- Generally low yield for Step exams
IL-17: “Neutrophils + chronic inflammation (psoriasis/SpA)”
Definition / source
- Produced mainly by Th17 cells (also some innate lymphoid cells)
Pathophysiology
- Promotes neutrophil recruitment and activation
- Stimulates production of other pro-inflammatory mediators
- Important for defense at mucosal/barrier surfaces against extracellular bacteria and fungi
Clinical presentation (very testable)
- Chronic mucocutaneous candidiasis risk when Th17/IL-17 pathway is impaired (boards love “Candida + T-cell issue”)
- Autoimmune/inflammatory diseases:
- Psoriasis
- Ankylosing spondylitis / spondyloarthropathies
- Some IBD involvement (but therapeutic nuance exists)
Diagnosis
- Clinical pattern recognition (psoriatic plaques; inflammatory back pain; recurrent mucocutaneous Candida)
Treatment / drug hooks
- Secukinumab, ixekizumab = anti–IL-17A
- Brodalumab = anti–IL-17 receptor
Used for psoriasis and some spondyloarthropathies.
First Aid tie-in
- Th17 → IL-17 → recruits neutrophils, associated with autoimmune inflammation.
High-yield clinical “cytokine vignettes” (what the stem is really asking)
1) Fever + acute inflammation + autoinflammatory syndrome
- Think IL-1 (also IL-6, TNF-α)
- Treatment clue: anakinra / canakinumab
2) High CRP + anemia of chronic disease
- Think IL-6 → hepcidin
- Treatment clue: tocilizumab
3) Neutrophils rushing in early
- Think IL-8 (chemotaxis)
4) Atopy/asthma + eosinophilia + high IgE
- Think Th2:
- IL-4 (IgE class switching)
- IL-5 (eosinophils)
- IL-13 (mucus, airway hyperreactivity)
- Drug clue: dupilumab (IL-4Rα), anti–IL-5 agents for eosinophilic asthma
5) Psoriasis / spondyloarthropathy + neutrophil-driven inflammation
- Think IL-17
- Drug clue: secukinumab/ixekizumab/brodalumab
6) Intracellular pathogens / granuloma logic
- Think IL-12 → Th1 → IFN-γ
- Drug clue: ustekinumab blocks IL-12/23 (psoriasis/IBD)
One-table cram sheet (IL-1 → IL-17)
| IL | Main source (HY) | Primary function | Classic Step association | Drug associations |
|---|---|---|---|---|
| IL-1 | Macrophages | Fever, endothelial activation, inflammation | Autoinflammatory periodic fevers | Anakinra, canakinumab |
| IL-3 | T cells | Bone marrow progenitors | Hematopoiesis support | — |
| IL-4 | Th2, mast cells | Th2 differentiation, IgE class switch | Atopy, asthma | Dupilumab (via IL-4Rα) |
| IL-5 | Th2 | Eosinophil growth/activation | Asthma, helminths, eosinophilia | Mepolizumab/reslizumab/benralizumab |
| IL-6 | Macrophages | Acute phase, fever, hepcidin | ↑CRP, anemia of chronic disease, RA | Tocilizumab |
| IL-7 | BM/thymic stroma | T- and B-cell development | Lymphopenia concept | — |
| IL-8 | Macrophages | Neutrophil chemotaxis | Acute bacterial inflammation | — |
| IL-9 | Th2 | Mast cell growth, mucus | Allergy “supporting actor” | — |
| IL-10 | Treg | Anti-inflammatory | Immune tolerance | — |
| IL-11 | Stromal cells | Megakaryocyte maturation | Platelet production (low yield) | — |
| IL-12 | Macrophages/DCs | Th1 differentiation, NK activation | Intracellular pathogens | Ustekinumab (IL-12/23) |
| IL-13 | Th2 | Mucus, airway hyperreactivity, IgE help | Asthma, atopy | Dupilumab (via IL-4Rα) |
| IL-15 | Mononuclear phagocytes | NK cell development; memory CD8 | NK biology | — |
| IL-16 | Various | CD4 chemoattractant | Low yield | — |
| IL-17 | Th17 | Neutrophil recruitment, inflammation | Psoriasis, Candida defense | Secukinumab, ixekizumab, brodalumab |
Fast recall mnemonics (optional but useful)
- IL-1: “1 = fever has one thermostat”
- IL-8: “Chem8axis” → neutrophils
- IL-5: “5 sounds like hive” → allergy/parasites → eosinophils
- IL-17: “Teenage cytokine = inflammation and acne-like neutrophils” (psoriasis/neutrophils)
Common pitfalls (what students mix up)
-
IL-8 vs IL-17:
- IL-8 = direct neutrophil chemotaxis (chemokine, immediate recruitment)
- IL-17 = Th17-driven inflammatory program that promotes neutrophil recruitment (often chronic/autoimmune context)
-
IL-4 vs IL-13:
- Both are Th2 and overlap, but:
- IL-4 = big test point for Th2 differentiation + IgE class switching
- IL-13 = mucus + airway hyperreactivity
-
IL-1 vs IL-6:
- Both can cause fever
- IL-6 is the classic for acute-phase reactants (CRP) + hepcidin
Where this shows up on Step questions (practical integration)
- Micro: Candida + impaired Th17/IL-17; intracellular pathogens + IL-12/Th1 axis
- Pharm: monoclonal antibodies (ustekinumab, secukinumab) and receptor antagonists (anakinra) tied to disease
- Path: acute-phase response, anemia of chronic disease (IL-6), neutrophil recruitment (IL-8/IL-17)